Cargando…
miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A
Biological function of microRNA-20c-3p (miRNA-520c-3p) in the progression of nasopharyngeal carcinoma (NPC) and the potential mechanism were investigated. Relative level of miRNA-520c-3p in NPC tissues and adjacent normal tissues was determined by quantitative real-time polymerase chain reaction (qR...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924133/ https://www.ncbi.nlm.nih.gov/pubmed/31897193 http://dx.doi.org/10.3892/ol.2019.11144 |
_version_ | 1783481670475710464 |
---|---|
author | Sun, Xiaohan Xu, Wenrui Zang, Chuanshan Li, Na |
author_facet | Sun, Xiaohan Xu, Wenrui Zang, Chuanshan Li, Na |
author_sort | Sun, Xiaohan |
collection | PubMed |
description | Biological function of microRNA-20c-3p (miRNA-520c-3p) in the progression of nasopharyngeal carcinoma (NPC) and the potential mechanism were investigated. Relative level of miRNA-520c-3p in NPC tissues and adjacent normal tissues was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Particularly, miRNA-520c-3p level in NPC with different tumor stages and tumor sizes was examined. Subsequently, miRNA-520c-3p level in nasopharyngeal epithelial cells and NPC cells was detected. The potential influence of miRNA-520c-3p on the proliferative ability and cell cycle progression of NPC cells were evaluated through cell counting kit-8 (CCK-8) and flow cytometry. The target gene of miRNA-520c-3p was verified by dual-luciferase reporter gene assay. Regulatory role of miRNA-520c-3p/RAB22A in the malignant progression of NPC was identified. miRNA-520c-3p was downregulated in NPC tissues and cell lines. Its level was lower in NPC with worse tumor grade and larger tumor size. Overexpression of miRNA-520c-3p suppressed the proliferative ability and arrested cell cycle in G0/G1 phase. RAB22A was confirmed to be the downstream target of miRNA-520c-3p. In NPC tissues and cell lines, RAB22A remained in higher abundance relative to controls. Overexpression of RAB22A reversed the inhibitory effects of overexpressed miRNA-520c-3p on proliferative ability and cell cycle progression of NPC cells. miRNA-520c-3p is downregulated in NPC, which accelerates the malignant progression of NPC by targeting RAB22A. |
format | Online Article Text |
id | pubmed-6924133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-69241332020-01-02 miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A Sun, Xiaohan Xu, Wenrui Zang, Chuanshan Li, Na Oncol Lett Articles Biological function of microRNA-20c-3p (miRNA-520c-3p) in the progression of nasopharyngeal carcinoma (NPC) and the potential mechanism were investigated. Relative level of miRNA-520c-3p in NPC tissues and adjacent normal tissues was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Particularly, miRNA-520c-3p level in NPC with different tumor stages and tumor sizes was examined. Subsequently, miRNA-520c-3p level in nasopharyngeal epithelial cells and NPC cells was detected. The potential influence of miRNA-520c-3p on the proliferative ability and cell cycle progression of NPC cells were evaluated through cell counting kit-8 (CCK-8) and flow cytometry. The target gene of miRNA-520c-3p was verified by dual-luciferase reporter gene assay. Regulatory role of miRNA-520c-3p/RAB22A in the malignant progression of NPC was identified. miRNA-520c-3p was downregulated in NPC tissues and cell lines. Its level was lower in NPC with worse tumor grade and larger tumor size. Overexpression of miRNA-520c-3p suppressed the proliferative ability and arrested cell cycle in G0/G1 phase. RAB22A was confirmed to be the downstream target of miRNA-520c-3p. In NPC tissues and cell lines, RAB22A remained in higher abundance relative to controls. Overexpression of RAB22A reversed the inhibitory effects of overexpressed miRNA-520c-3p on proliferative ability and cell cycle progression of NPC cells. miRNA-520c-3p is downregulated in NPC, which accelerates the malignant progression of NPC by targeting RAB22A. D.A. Spandidos 2020-01 2019-11-25 /pmc/articles/PMC6924133/ /pubmed/31897193 http://dx.doi.org/10.3892/ol.2019.11144 Text en Copyright: © Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Sun, Xiaohan Xu, Wenrui Zang, Chuanshan Li, Na miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title | miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title_full | miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title_fullStr | miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title_full_unstemmed | miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title_short | miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A |
title_sort | mirna-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting rab22a |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924133/ https://www.ncbi.nlm.nih.gov/pubmed/31897193 http://dx.doi.org/10.3892/ol.2019.11144 |
work_keys_str_mv | AT sunxiaohan mirna520c3pacceleratesprogressionofnasopharyngealcarcinomaviatargetingrab22a AT xuwenrui mirna520c3pacceleratesprogressionofnasopharyngealcarcinomaviatargetingrab22a AT zangchuanshan mirna520c3pacceleratesprogressionofnasopharyngealcarcinomaviatargetingrab22a AT lina mirna520c3pacceleratesprogressionofnasopharyngealcarcinomaviatargetingrab22a |